![](https://static.youtibao.com/asksite/comm/h5/images/m_q_title.png)
[多选题]
卡瑞利珠单抗联合阿帕替尼和化疗用于晚期食管鳞癌一线治疗的临床研究中联合药物为()
A.奈达铂
B.力扑素
C.替吉奥
D.白蛋白紫杉醇
![](https://static.youtibao.com/asksite/comm/h5/images/m_q_a.png)
AB
![](https://static.youtibao.com/asksite/comm/h5/images/solist_ts.png)
A.奈达铂
B.力扑素
C.替吉奥
D.白蛋白紫杉醇
AB
A.2 (4.8%)
B.23 (54.8%)
C.12 (28.6%)
D.4 (9.5%)
A.59.5%,7.6个月,未达到
B.59.5%,7.6个月,12.1个月
C.59.5%,8.6个月,12.1个月
D.59.5%,7.6个月,13.1个月
A.卡瑞利珠单抗200mgQ2W+阿帕替尼500mgQD
B.卡瑞利珠单抗200mgQ3W+阿帕替尼250mgQD
C.卡瑞利珠单抗200mgQ3W+阿帕替尼500mgQD
D.卡瑞利珠单抗200mgQ2W+阿帕替尼250mgQD